Total Number of Communication Reports: 9
Monthly communication reports in the last 6 months: 0
Subject matters | Details | Categories |
---|---|---|
Health
|
Title: Amendment to the Special Access Program, with respect to the proposed amendment to allow access to schedule J drugs.
Lobbying to help patients and doctors better access their medicine (Psiloocybin).
|
Regulation, Policies or Program, Grant, Contribution or Other Financial Benefit
|
Health
|
Title: Canadian Institute of Health Research with respect to promoting patient-centered psilocybin research in Canada
|
Policies or Program, Grant, Contribution or Other Financial Benefit
|
Health
|
Title: Development of Psilocybin Access Regulations with respect to the Canadian drugs and controlled substances act and Food and drug regulations.
Lobbying to help patients and doctors access psilocybin through special regulations.
|
Regulation, Legislative Proposal, Bill or Resolution
|
Address:
2031 Store St
Victoria, BC V8T 5L9
Canada
Telephone number:
647-542-7465
Bruce Tobin, Founder and Chairman Of Board of Directors
TheraPsil / TheraPsil is not a subsidiary of any other parent companies.
TheraPsil / TheraPsil is not a coalition.
The activities of TheraPsil / TheraPsil are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
TheraPsil / TheraPsil does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Spencer Hawkswell | No public offices held